Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting

Novavax Inc. (NASDAQ: NVAX) is facing renewed pressure from its largest shareholder, Shah Capital, after the biotech company secured approval for all... Read More

The post Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting appeared first on citybiz.